Hims vs. Novo Nordisk: Why the Pharma Giant Might Avoid a Legal Fight

Hims is selling a $49 copycat of Novo Nordisk's $149 weight-loss pill, but legal experts say Novo may avoid court battles due to risks of setting dangerous precedents.

Hims vs. Novo Nordisk: Why the Pharma Giant Might Avoid a Legal Fight
Credit: Charlotte de la Fuente/Bloomberg
Already have an account? Sign in.